Troubles du Sommeil : 4 Vérités choquantes
dont votre médecin ne vous a jamais parlé

Référence scientifiques

Cette présentation a été élaborée à partir des données émanant des instituts suivants :

1) Kumari M , Badrick E , Ferrie J , Perski A , Marmot M , Chandola T 2009 Self-reported sleep duration and sleep disturbance are independently associated with cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab 94:4801–4809
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795654/

2) C. Castro-Diehl, A.V. Diez Roux, S. Redline, T. Seeman, S.E. Shrager, S. Shea
Association of sleep duration and quality with alterations in the hypothalamic–pituitary–adrenocortical axis: the multi-ethnic study of atherosclerosis (MESA) J. Clin. Endocrinol. Metab., 100 (2015), pp. 3149-3158
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524997/

3) Vgontzas, A. N., Tsigos, C., Bixler, E. O., Stratakis, C. A., Zachman, K., Kales, A., et al. (1998). Chronic insomnia and activity of the stress system: A preliminary study. Journal of Psychosomatic Research, 45, 21–31.
https://www.ncbi.nlm.nih.gov/pubmed/9720852

4) Collier J. Big pharma and the UK Government
The Lancet, Volume 367, No. 9505, p97–98, 14 January 2006
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(06)67943-9/fulltext

5) Cordi MJ, Schlarb AA, Rasch B. Deepening sleep by hypnotic suggestion. SLEEP 2014;37(6):1143-1152.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015388/

6) Billioti de Gage S Moride Y Ducruet T Kurth T Verdoux H Tournier M Pariente A Bégaud B (2014) Benzodiazepine use and risk of Alzheimer’s disease: case-control study. BMJ 9 ;349:g5205.
http://www.bmj.com/content/349/bmj.g5205

7) Billioti de Gage S, Pariente A, Begaud B. Is there really a link between benzodiazepine use and the risk of dementia? Expert opinion on drug safety. 2015:1–15.
https://www.ncbi.nlm.nih.gov/pubmed/25691075

8) Zhong G, Wang Y, Zhang Y, Zhao Y. 2014. Association between benzodiazepine use and dementia: a meta-analysis. PLoS One 10(5): e0127836. DOI:10.1371/journal. pone.0127836
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446315/

9) TAKADA, M.; FUJIMOTO, M.; HOSOMI, K. Association between Benzodiazepine Use and Dementia: Data Mining of Different Medical Databases. International journal of Medical Sciences, v. 13, n. 11, p. 825–834, 2016.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118753/

10) Baron KG, Reid KJ, Zee PC. Exercise to improve sleep in insomnia: exploration of the bidirectional effects. J Clin Sleep Med. 2013;9:819–24.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716674/

11) Abell, J. G., Shipley, M. J., Ferrie, J. E., Kivimäki, M., & Kumari, M. (2016). Recurrent short sleep, chronic insomnia symptoms and salivary cortisol: A 10-year follow-up in the Whitehall II study. Psychoneuroendocrinology, 68, 91–99.
http://www.sciencedirect.com/science/article/pii/S0306453016300518

12) Rodenbeck AHuether GRuther EHajak G Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett 2002;324159- 163
https://www.ncbi.nlm.nih.gov/pubmed/11988351/

13) Vgontzas, A. N., Bixler, E. O., Lin, H.-M., Prolo, P., Mastorakos, G., Vela-Bueno, A., et al. (2001). Chronic insomnia is associated with nyctohemeral activation of the hypothalamic–pituitary–adrenal axis: Clinical implications. The Journal of Clinical Endocrinology & Metabolism, 86, 3787–3794.
https://www.ncbi.nlm.nih.gov/pubmed/11502812

14) Xia L, Chen GH, Li ZH, Jiang S, Shen J. Alterations in hypothalamus-pituitary-adrenal/thyroid axes and gonadotropin-releasing hormone in the patients with primary insomnia: a clinical research. PLoS ONE. 2013;8(8):e71065.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739817/

15) Kripke DF. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Res. 2016;5:918.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890308/

16) Simon Beaulieu-Bonneau, Mélanie LeBlanc, Chantal Mérette, Yves Dauvilliers, Charles M. Morin; Family History of Insomnia in a Population-Based Sample, Sleep, Volume 30, Issue 12, 1 December 2007, Pages 1739–1745
https://academic.oup.com/sleep/article/30/12/1739/2696927

17) Dauvilliers Y, Morin C, Cervena K, et al. Family studies in insomnia. J Psychosom Res 2005;58:271-8.
https://www.ncbi.nlm.nih.gov/pubmed/15865952

18) Allaert FA, Urbinelli R. Sociodemographic profile of insomniac patients
across national surveys. CNS Drugs 2004;18(Suppl 1):3–7.
https://www.ncbi.nlm.nih.gov/pubmed/15291008

19) OHAYON M.M. - Prévalence et comorbidité des troubles du sommeil dans la population générale. La revue du Praticien. 2007, 57, 1521-1528.
http://www.sfrms-sommeil.org/IMG/pdf/prevalence-comorbidite.pdf

20) ] Quera-Salva MA, Orluc A, Goldenberg F, Guilleminault C. Insomnia and use of hypnotics: study of a French population. Sleep 1991;14:386–91.
https://www.ncbi.nlm.nih.gov/pubmed/1759090

21) Sachar, E. J., Fishman, J. R., & Mason, J. W. (1965). Influence of the hypnotic trance on plasma 17-hydroxycorticosteroid concentration. Psychosomatic Medicine, 27(4), 330-341.
http://journals.lww.com/psychosomaticmedicine/Abstract/1965/07000/Influence_of_the_Hypnotic_Trance_on_Plasma.4.aspx

22) SACHAR EJ, COBB JC, SHOR RE. Plasma Cortisol Changes During Hypnotic Trance Relation to Depth of Hypnosis. Arch Gen Psychiatry. 1966;14(5):482–490. doi:10.1001/archpsyc.1966.01730110034005
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/489024

23) ZACHARIAE, R., BJERRING, P., ZACHARIAE, C., ARENDT-NIELSEN, L., NIELSEN, T., ELDRUP, E., LARSEN, C. S. and GOTLIEBSEN, K. (1991), Monocyte Chemotactic Activity in Sera after Hypnotically Induced Emotional States. Scandinavian Journal of Immunology, 34: 71–79. doi:10.1111/j.1365-3083.1991.tb01522.x
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3083.1991.tb01522.x/abstract

24) Kendrick, C., Johnson, A. K., Sliwinski, J., Patterson, V., Fisher, W. I., Elkins, G. R., & Carpenter, J. S. (2015). Hypnotic relaxation therapy for reduction of hot flashes in postmenopausal women: Examination of cortisol as a potential mediator. International Journal of Clinical and Experimental Hypnosis, 63(1), 76-91.
https://www.ncbi.nlm.nih.gov/pubmed/25365128

25) Varga K, Kekecs Z. Oxytocin and cortisol in the hypnotic interaciton. International Journal of Clinical and Experimental Hypnosis. 2014;62:84–110.
https://www.ncbi.nlm.nih.gov/pubmed/24256482

26) Schlarb, A.A., 2005. Verhaltenstherapie und Hypnotherapie bei primärer Insomnie. Eberhard-Karls Universität Tübingen (June 20)
https://publikationen.uni-tuebingen.de/xmlui/handle/10900/48758

27) Stanton, Harry E. (1999). Hypnotic Relaxation and Insomnia: A Simple Solution? Sleep and Hypnosis, Vol 1(1), 64-67.
http://sleepandhypnosis.org/ing/Pdf/5a7ec6f515ba47e9b5295fff2e7702cf.pdf

28) http://www.ont-hypnosis-centre.com/studies-proving-effectiveness-hypnosis-0/